携带人MST4或人dnMST4转基因的肺癌细胞株构建
Construction of Non-Small Cell Lung Cancer (NSCLC) Cell Lines Stably Overexpressing MST4 or dnMST4 Transgenes
DOI: 10.12677/ACM.2023.131030, PDF,    科研立项经费支持
作者: 韩留鑫*, 夏加伟*, 李云珍, 朱江春, 沈含章, 周玮莎:昆明市第三人民医院(云南省传染性疾病临床医学中心,大理大学第六附属医院),重症医学科,血液净化中心,云南 昆明;赵文淘#:昆明医科大学第三附属医院(云南省肿瘤医院,云南省癌症中心),消化肿瘤内科,云南 昆明;李 静, 肖 东:南方医科大学肿瘤研究所,广东 广州
关键词: MST4dnMST4慢病毒载体肺癌MST4 dnMST4 Lentivirus Vector Lung Cancer
摘要: 目的:利用慢病毒感染分别建立稳定过表达MST4和dnMST4的人肺癌细胞株。方法:分别以pcDNA3.1-MST4、pcDNA3.1-MST4 T178A质粒为模板,PCR分别扩增MST4、MST4 T178A序列(均为1.251 kb),片段两侧分别添加EcoR I/BamH I和Xba I/BamH I酶切位点,分别In-Fusion克隆至pCDH-RFP和pHEZG中,次日挑选单克隆菌落,提取质粒并进行测序和酶切鉴定;所构建的载体分别命名为pCDH-MST4-RFP和pHEZG-dnMST4。按标准程序进行慢病毒包装,并确认是否成功生产慢病毒;用携带MST4和RFP基因的慢病毒分别感染人肺癌细胞A549和HCC827,用携带dnMST4和GFP基因的慢病毒分别感染人肺癌细胞A549和HCC827,以建立稳定过表达MST4和dnMST4的人肺癌细胞系。应用qRT-PCR和Westernblot检测所建立肺癌细胞系中MST4和dnMST4在RNA层面和蛋白层面的表达水平。结果:测序和酶切鉴定的结果均证实成功构建了pCDH-MST4-RFP和pHEZG-dnMST4,按标准程序生产的携带MST4和RFP基因以及携带dnMST4和GFP基因的慢病毒均能成功感染人肺癌细胞。结论:成功构建稳定过表达MST4或dnMST4的人肺癌细胞株,为进一步研究MST4在肺癌恶性进程中的生物学功能及机制打下了良好基础。
Abstract: Objective: To establish non-small cell lung cancer (NSCLC) cell lines stably overexpressing MST4 and dnMST4 Transgenes by lentivirus infection, respectively. Methods: The fragment of human MST4 gene was amplified by PCR from the template of pcDNA3.1-MST4, and subsequently cloned into the plasmid of pCDH-RFP to obtain the final vector of pCDH-MST4-RFP, which was used to produce lenti-viruses carrying MST4 and RFP genes. The fragment of human dnMST4 gene was also amplified by PCR from the template of pcDNA3.1-MST4 T178A, and subsequently cloned into the plasmid of pHEZG to obtain the final vector of pHEZG-dnMST4, which was used to produce lentiviruses carrying dnMST4 and GFP genes. To establish human NSCLC cell lines stably overexpressing MST4 or dnMST4, lentiviruses harboring MST4 and RFP genes were employed to infect A549 and HCC827 cells, and lentiviruses harboring dnMST4 and GFP genes were also employed to infect A549 and HCC827 cells. The expression levels of MST4 and dnMST4 in the infected lung cancer cell lines at RNA and protein levels were detected by Western blot and qRT-PCR. Results: The lentivirus vector of pCDH-MST4-RFP and pHEZG-dnMST4 were successfully constructed. NSCLC cell lines A549 and HCC827 harboring MST4 and RFP transgenes were generated showing the expression of both MST4 and RFP transgenes. And the cell lines harboring dnMST4 and GFP transgenes were also generated showing the expression of both dnMST4 and GFP transgenes. Conclusion: NSCLC cell lines A549 and HCC827 stably expressing MST4 and dnMST4 transgenes were generated, which had laid a great foundation for further research on the biological function and mechanism of MST4 in the malignant process of lung cancer.
文章引用:韩留鑫, 夏加伟, 李云珍, 朱江春, 沈含章, 周玮莎, 赵文淘, 李静, 肖东. 携带人MST4或人dnMST4转基因的肺癌细胞株构建[J]. 临床医学进展, 2023, 13(1): 191-200. https://doi.org/10.12677/ACM.2023.131030

参考文献

[1] Zheng, R.S., Zhang, S.W., Zeng, H.M., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the Na-tional Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
[2] Yang, T., Xiong, Y., Zeng, Y., et al. (2022) Current Status of Immunotherapy for Non-Small Cell Lung Cancer. Frontiers in Pharmacology, 13, Article ID: 989461. [Google Scholar] [CrossRef] [PubMed]
[3] 张文谦, 李辉. 肺癌侵袭及转移机制的研究进展[J]. 中国临床新医学, 2022, 15(3): 198-201.
[4] 贾俊双, 孙妍, 肖东, 等. 慢病毒介导的外源基因体外投递系统的建立[J]. 热带医学杂志, 2008, 8(10): 1028-1029.
[5] 赵文淘, 赵尊兰, 史俊文, 等. 稳定过表达miR-26a肝癌细胞株的建立[J]. 热带医学杂志, 2013, 13(2): 140-142.
[6] Boettcher, S., Miller, P.G., Sharma, R., et al. (2019) A Dominant-Negative Effect Drives Selection of TP53 Missense Mutations in Myeloid Malignancies. Science, 365, 599-604. [Google Scholar] [CrossRef] [PubMed]
[7] Yeh, P.Y., Yeh, K.H., Chuang, S.E., et al. (2004) Suppres-sion of MEK/ERK Signaling Pathway Enhances Cisplatin-Induced NF-kappaB Activation by Protein Phosphatase 4-Mediated NF-kappaB p65 Thr Dephosphorylation. Journal of Biological Chemistry, 279, 26143-26148. [Google Scholar] [CrossRef
[8] Qian, Z., Lin, C., Espinosa, R., et al. (2001) Cloning and Characteri-zation of MST4, a Novel Ste20-Like Kinase. Journal of Biological Chemistry, 276, 22439-22445. [Google Scholar] [CrossRef
[9] Lin, J.L., Chen, H.C., Fang, H.I., et al. (2001) MST4, a New Ste20-Related Kinase That Mediates Cell Growth and Transformation via Modulating ERK Pathway. Oncogene, 20, 6559-6569. [Google Scholar] [CrossRef] [PubMed]
[10] Hao, W.C., Zhong, Q.L., Pang, W.Q., et al. (2020) MST4 Inhibits Human Hepatocellular Carcinoma Cell Proliferation and Induces Cell Cycle Arrest via Suppression of PI3K/AKT Pathway. Journal of Cancer, 11, 5106-5117. [Google Scholar] [CrossRef] [PubMed]
[11] Han, X.M., Tian, P.Y., et al. (2019) MicroRNA-486-5p Inhibits Ovarian Granulosa Cell Proliferation and Participates in the Development of PCOS via Targeting MST4. European Review for Medical and Pharmacological Sciences, 23, 7217-7223.
[12] Shi, Z., Jiao, S., Zhang, Z., et al. (2013) Structure of the MST4 in Complex with MO25 Provides Insights into Its Activation Mechanism. Structure, 21, 449-461. [Google Scholar] [CrossRef] [PubMed]
[13] Jiao, S., Zhang, Z., Li, C., et al. (2015) The Kinase MST4 Limits In-flammatory Responses through Direct Phosphorylation of the Adaptor TRAF6. Nature Immunology, 16, 246-257. [Google Scholar] [CrossRef] [PubMed]
[14] Caputo, M., Cansby, E., Kumari, S., et al. (2021) STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes. Hepatology Communications, 5, 1183-1200. [Google Scholar] [CrossRef] [PubMed]
[15] Ma, X., Zhao, H., Shan, J., et al. (2007) PDCD10 Interacts with Ste20-Related Kinase MST4 to Promote Cell Growth and Transformation via Modulation of the ERK Pathway. Molecu-lar Biology of the Cell, 18, 1965-1978. [Google Scholar] [CrossRef] [PubMed]
[16] Lin, Z.H., Wang, L., Zhang, J.B., et al. (2014) MST4 Promotes Hepatocellular Carcinoma Epithelial-Mesenchymal Transition and Metastasis via Activation of the p-ERK Pathway. In-ternational Journal of Oncology, 45, 629-640. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, S.C., Lin, X.L., Li, J., et al. (2014) MicroRNA-122 Triggers Mesenchymal-Epithelial Transition and Suppresses Hepatocellular Carcinoma Cell Motility and Invasion by Targeting RhoA. PLOS ONE, 9, e101330. [Google Scholar] [CrossRef] [PubMed]
[18] 龙春庭, 邵敏, 陆小云. 激酶小分子抑制剂研究进展[J]. 药学学报, 2021, 56(2): 414-431.
[19] Roskoski, R. (2022) Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors: A 2022 Update. Pharmacological Research, 175, Article ID: 106037. [Google Scholar] [CrossRef] [PubMed]